Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mirakl provides marketplace and dropship platform solutions that enable businesses—including those in healthcare—to expand product assortments, manage supplier catalogs, and streamline procurement using AI and real-time analytics. The company has powered digital marketplaces for healthcare supply distribution during the COVID pandemic but does not develop therapeutics or diagnostics itself. Notably, during the COVID crisis, Mirakl partnered with the French government to launch StopCOVID19.fr—a B2B marketplace centralizing essential medical supplies for hospitals and public institutions. In the US, Premier Inc. used the Mirakl platform to power "stockd", a B2B e-commerce marketplace for medical supplies serving thousands of healthcare providers. However, these are applications of their software; Mirakl itself does not conduct drug development or clinical research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mirakl.